Arbutus Biopharma Corporation ( ABUS ) is currently at $2.96, down $0.27 or 8.2%
--Would be lowest close since June 20, 2024, when it closed at $2.95
--On pace for largest percent decrease since April 25, 2023, when it fell 12.46%
--Currently down two consecutive days; down 15.53% over this period
--Worst two day stretch since the two days ending April 25, 2023, when it fell 15.67%
--Down 15.04% month-to-date
--Down 9.33% year-to-date
--Down 90.42% from its all-time closing high of $30.94 on March 11, 2014
--Down 4.05% from 52 weeks ago (April 8, 2024), when it closed at $3.09
--Down 34.98% from its 52-week closing high of $4.56 on Sept. 11, 2024
--Up 12.31% from its 52-week closing low of $2.64 on April 22, 2024
--Traded as low as $2.89; lowest intraday level since May 17, 2024, when it hit $2.89
--Down 10.53% at today's intraday low; largest intraday percent decrease since Aug. 5, 2024, when it fell as much as 11.65%
All data as of 11:17:43 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 07, 2025 11:20 ET (15:20 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.